Key points are not available for this paper at this time.
APSAC achieves reperfusion in AMI; extends early RCT evidence for bolus fibrinolytic therapy in STEMI.
Journal Article The use of BRL26921 (APSAC) as fibrinolytic therapy in acute myocardial infarction Get access W. S. HILLIS, W. S. HILLIS Department of Materia Medica, University of Glasgow, Stobhill General HospitalBalornock Road, Glasgow G21 3UW, U.K. Search for other works by this author on: Oxford Academic PubMed Google Scholar R. S. HORNUNG R. S. HORNUNG Department of Materia Medica, University of Glasgow, Stobhill General HospitalBalornock Road, Glasgow G21 3UW, U.K. Search for other works by this author on: Oxford Academic PubMed Google Scholar European Heart Journal, Volume 6, Issue 11, November 1985, Pages 909–912, https://doi.org/10.1093/oxfordjournals.eurheartj.a061787 Published: 01 November 1985
No takes yet. Share an insight, caveat, or question.
Hillis et al. (1985) studied this question.